We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Identification and characterization of a novel endogenous murine parkin mutation.
- Authors
Ramsey, Chenere P.; Giasson, Benoit I.
- Abstract
J. Neurochem. (2010) 113, 402–417. Various mutations in the PARK2 gene which encodes the protein, parkin, are causal of a disease entity-termed autosomal recessive juvenile parkinsonism. Parkin can function as an E3 ubiquitin-protein ligase, mediating the ubiquitination of specific targeted proteins and resulting in proteasomal degradation. Parkin is thought to lead to parkinsonism as a consequence of a loss in its function. In this study, immunoblot analyses of brain extracts from Balb/c, C57BL/6, C3H, and 129S mouse strains demonstrated significant variations in immunoreactivity with anti-parkin monoclonal antibodies (PRK8, PRK28, and PRK109). This resulted partly from differences in the steady-state levels of parkin protein across mouse strains. There was also a complete loss of immunoreactivity for PRK8 and PRK28 antibodies in C3H mice due to was because of a homologous nucleotide mutation resulting in an E398Q amino acid substitution. In cultured cells, parkin harboring this mutation had a greater tendency to aggregate, exhibited reduced interaction with the E2 ubiquitin-conjugating enzymes, UbcH7 and UbcH8, and demonstrated loss-of-function in promoting the proteosomal degradation of a specific putative substrate, synphilin-1. In situ, C3H mice displayed age-dependent increased levels of brain cortical synphilin-1 compared with C57BL/6, suggesting that E398Q parkin in these mice is functionally impaired and that C3H mice may be a suitable model of parkin loss-of-function similar to patients with missense mutations.
- Subjects
GENETIC mutation; IMMUNOGLOBULINS; BRAIN diseases; PARKINSON'S disease; MOLECULAR cloning
- Publication
Journal of Neurochemistry, 2010, Vol 113, Issue 2, p402
- ISSN
0022-3042
- Publication type
Article
- DOI
10.1111/j.1471-4159.2010.06605.x